Clinical trial • Phase I • Neurology

metoclopramide for Alzheimer's disease|Healthy volunteers

Phase I trial of metoclopramide for Alzheimer's disease|Healthy volunteers. 85 participants.

Overview

Trial Therapeutic Area
Neurology
Trial Disease
Alzheimer's disease|Healthy volunteers
Trial Stage
Phase I
Drug Modality
Radiopharmaceutical

Key dates

Initial CTIS Submission Date
21-11-2024
First CTIS Authorization Date
15-01-2025

Trial design

Phase I trial across 1 site in Austria.

Target Sample Size
85

Eligibility

Recruits 85 Vulnerable populations not selected; no consent/assent procedures described.

Vulnerable Population
Vulnerable populations not selected; no consent/assent procedures described

Recruitment

Planned Sample Size
85
Recruitment Window Months
140

Geography

Total Number Of Sites
1
Total Number Of Participants
85

Austria

Earliest CTIS Part Ii Submission Date
02-12-2024
Latest Decision Or Authorization Date
15-01-2025
Processing Time Days
44
Number Of Sites
1
Number Of Participants
85

Sites

Site Name
Medical University Of Vienna
Department Name
Department of Clinical Pharmacology
Contact Person Name
Markus Zeitlinger

Sponsor

Primary sponsor

Full Name
Medical University Of Vienna
Organisation Type
Educational Institution
Country Of Registered Address
Austria

Investigational products

Investigational Product Name
[11C]metoclopramide
Active Substance
metoclopramide
Modality
Radiopharmaceutical

Related trials

Other published trials that may interest you.